Werner Geldenhuys
Associate Chairperson
Pharmaceutical Sciences
West Virginia University
United States of America
Biography
Dr. Geldenhuys graduated from Potchefstroom University, South Africa (now North-West University) in 1999 with a bachelor of Pharmacy degree. He then went on the receive a Doctor of Philosophy in medicinal chemistry/neuroscience (2004) after completing a Master’s degree in medicinal chemistry (2002), both from North-West University. After graduation he did a post-doctoral research at Texas Tech School of Pharmacy. In 2007 he joined as the first faculty member in the Department of Pharmaceutical Sciences of the newly established College of Pharmacy at Northeast Ohio Medical University (NEOMED), Rootstown, OH. His research is focused on the development of novel neuroprotective compounds to slow the progression of neurodegenerative diseases including Parkinson’s and Alzheimer’s disease and stroke.
Research Interest
development of novel neuroprotective compounds
Publications
-
Geldenhuys WJ, Guseman TL, Pienaar IS, Dluzen DE, Young JW. A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson’s disease. PeerJ. 2015 Aug 11;3:e1175.
-
Geldenhuys WJ, Cudnik ML, Krinsky DL, Darvesh AS. Evolution of a natural products and nutraceuticals course in the pharmacy curriculum. American journal of pharmaceutical education. 2015 Aug 25;79(6):82.
-
Young LM, Geldenhuys WJ, Domingo OC, Malan SF, Van der Schyf CJ. Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltageâ€Gated Calcium Channel Blockers. Archiv der Pharmazie. 2016 Apr 1;349(4):252-67.
